Dalbavancin In Vitro Activity Obtained against Gram-positive Clinical Isolates Causing Bone and Joint Infections in USA and European Hospitals (2011-2015)
Dalbavancin In Vitro Activity Obtained against Gram-positive Clinical Isolates Causing Bone and Joint Infections in USA and European Hospitals (2011-2015), Lead author: Mendes RE, presented at ID Week 2016, October 26-30, 2016, New Orleans, LA, USA
Poster 1834